BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 2502790)

  • 1. Inhibition of brain dopa-decarboxylase by RO 4-4602 infused ICV blocks alcohol drinking induced in rats by cyanamide.
    Miñano FJ; Myers RD
    Psychopharmacology (Berl); 1989; 98(2):176-82. PubMed ID: 2502790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Central action of an inhibitor of brain dopa-decarboxylase, NSD-1015, on cyanamide-induced alcohol drinking in rats.
    Miñano FJ; McMillen BA; Myers RD
    Pharmacol Biochem Behav; 1990 Feb; 35(2):465-8. PubMed ID: 2320657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of tetrahydropapaveroline with inhibition of dopa-decarboxylase by Ro 4-4602 in brain: effects on alcohol drinking in the rat.
    Miñano FJ; McMillen BA; Myers RD
    Alcohol; 1989; 6(2):133-7. PubMed ID: 2713086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyanamide given ICV or systemically to the rat alters subsequent alcohol drinking.
    Critcher EC; Myers RD
    Alcohol; 1987; 4(5):347-53. PubMed ID: 3675855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective reduction by the 5-HT antagonist amperozide of alcohol preference induced in rats by systemic cyanamide.
    Myers RD; Lankford M; Björk A
    Pharmacol Biochem Behav; 1992 Nov; 43(3):661-7. PubMed ID: 1448464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drinking patterns in genetic low-alcohol-drinking (LAD) rats after systemic cyanamide and cerebral injections of THP or 6-OHDA.
    West MW; Biggs TA; Tavares E; Lankford MF; Myers RD
    Alcohol; 1998 Apr; 15(3):239-47. PubMed ID: 9539382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age dependent development of ethanol drinking in rats after inhibition of aldehyde dehydrogenase.
    Barwick VS; Myers RD
    Alcohol; 1992; 9(6):501-7. PubMed ID: 1472305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alcohol intake in high alcohol drinking (HAD) rats is suppressed by FG5865, a novel 5-HT1A agonist/5-HT2 antagonist.
    Long TA; Kalmus GW; Björk A; Myers RD
    Pharmacol Biochem Behav; 1996 Jan; 53(1):33-40. PubMed ID: 8848457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of cyanamide and clofibrate on the enzymes of ethanol oxydation and on ethanol consumption in the rat.
    Lamboeuf Y; De Saint Blanquat G
    Arch Int Pharmacodyn Ther; 1980 Jan; 243(1):17-26. PubMed ID: 6992725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Naloxone alters alcohol drinking induced in the rat by tetrahydropapaveroline (THP) infused ICV.
    Myers RD; Critcher EC
    Pharmacol Biochem Behav; 1982 May; 16(5):827-36. PubMed ID: 6283568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of alcohol drinking with brain aldehyde dehydrogenase inhibition.
    Sinclair JD; Lindros KO
    Pharmacol Biochem Behav; 1981 Mar; 14(3):377-83. PubMed ID: 7232463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Irreversible suppression of alcohol drinking in cyanamide-treated rats after sustained delivery of the 5-HT2 antagonist amperozide.
    Myers RD; Lankford M; Björk A
    Alcohol; 1993; 10(2):117-25. PubMed ID: 8442888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blockade of 5-HTp reduction of ethanol drinking with the decarboxylase inhibitor, ro 4-4602.
    Geller I; Hartmann RJ; Messiha FS
    Pharmacol Biochem Behav; 1981 Dec; 15(6):871-4. PubMed ID: 6976579
    [No Abstract]   [Full Text] [Related]  

  • 14. Ingestion, body weight and activity of rats receiving repeated intracerebroventricular infusions of rat satietin.
    Bellinger LL; Mendel VE
    Physiol Behav; 1988; 44(4-5):445-52. PubMed ID: 3237837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-HT2 receptor blockade by amperozide suppresses ethanol drinking in genetically preferring rats.
    Myers RD; Lankford MF; Björk A
    Pharmacol Biochem Behav; 1993 Jul; 45(3):741-7. PubMed ID: 8332634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyanamide injections during alcohol deprivation increase alcohol drinking.
    Sinclair JD; Gribble PA
    Alcohol; 1985; 2(4):627-30. PubMed ID: 4026987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of VB6 on L-DOPA decarboxylase activity in the organs of rats given peripheral L-DOPA decarboxylase inhibitors (author's transl)].
    Yoshimine N; Kuzuya F; Mori K; Sakamoto N
    Nihon Ronen Igakkai Zasshi; 1978 Nov; 15(6):566-73. PubMed ID: 732010
    [No Abstract]   [Full Text] [Related]  

  • 18. Failure of the 5-HT2 receptor antagonist, ritanserin, to alter preference for alcohol in drinking rats.
    Myers RD; Lankford MF
    Pharmacol Biochem Behav; 1993 May; 45(1):233-7. PubMed ID: 8516364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attenuation of alcohol drinking in tetrahydroisoquinoline-treated rats by morphine and naltrexone.
    Critcher EC; Lin CI; Patel J; Myers RD
    Pharmacol Biochem Behav; 1983 Feb; 18(2):225-9. PubMed ID: 6835979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effect of benserazide on catecholamine concentrations in the rat pineal, cerebral cortex and hypothalamus.
    Ho AK; Smith JA
    Biochem Pharmacol; 1983 Dec; 32(23):3605-9. PubMed ID: 6651878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.